Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Gemfibrozil

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 65Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ascent Pharms`s Generic Gemfibrozil Receives Approval In US
    Ascent Pharms`s Generic Gemfibrozil Receives Approval In US

    16 Jan 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214603

    FDA
    16 Jan 2021
    Share Share
    Zydus Pharms USA's Generic Gemfibrozil Receives Approval in US
    Zydus Pharms USA's Generic Gemfibrozil Receives Approval in US

    31 Aug 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204189

    FDA
    31 Aug 2018
    Share Share
    Zydus Cadila gets USFDA nod to market 2 products
    Zydus Cadila gets USFDA nod to market 2 products

    29 Aug 2018

    // ECONOMIC TIMES

    https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-usfda-nod-to-market-2-products/65606581

    ECONOMIC TIMES
    29 Aug 2018
    Share Share
    Aurobindo's Generic Gemfibrozil (600mg) approved in US to lower lipid levels
    Aurobindo's Generic Gemfibrozil (600mg) approved in US to lower lipid levels

    16 Sep 2015

    // FDA

    https://www.pharmacompass.com/pdf/news/aurobindos-generic-gemfibrozil-600mg-approved-in-us-to-lower-lipid-levels-1442662189.pdf

    FDA
    16 Sep 2015
    Share Share